Insider · CIK 0001798744
Ricci S Whitlow
Files at MDXG (MIMEDX GROUP, INC.). First filing Feb 16, 2024, latest Feb 21, 2024.
In brief
Ricci S Whitlow files SEC Form 4 as COO at MDXG (MIMEDX GROUP, INC.). Since Feb 16, 2024, Ricci S Whitlow has reported 0 open-market buys worth $0 and 2 open-market sells worth $497k, the latest filed on Feb 21, 2024.
A track record needs three past buys with six months of prices behind them; Ricci S Whitlow has 0, so none is measured yet.
The newest scored trade: sold $247k of MDXG on Feb 16, 2024, filed Feb 21, 2024, scored 33 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MDXG: MIMEDX GROUP, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | MDXGsell MIMEDX GROUP, INC. | $247k 30,764 shares | -7% | +157% from low-12% from high | |
| 33Weak | MDXGsell MIMEDX GROUP, INC. | $250k 31,043 shares | -7% | +157% from low-12% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 20, 2024 | MDXG MIMEDX GROUP, INC. | 15,271 0.01% of outstanding | $122k | Feb 20, 2024 | $375k |
| Feb 16, 2024 | MDXG MIMEDX GROUP, INC. | 15,493 0.01% of outstanding | $125k | Feb 16, 2024 | $250k |
| Feb 15, 2024 | MDXG MIMEDX GROUP, INC. | 15,198 0.01% of outstanding | $122k | Feb 15, 2024 | $127k |
| Feb 14, 2024 | MDXG MIMEDX GROUP, INC. | 15,845 0.01% of outstanding | $127k | Feb 14, 2024 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | MDXG MIMEDX GROUP, INC. | AGrant or award Common Stock | +74,163 | $0.00 | $0 | 462,825 | Mar 6, 2026 |
| Mar 4, 2026 | MDXG MIMEDX GROUP, INC. | AGrant or award Stock Optionsderivative | +62,068 | $0.00 | $0 | 169,309 | Mar 6, 2026 |
| Feb 13, 2026 | MDXG MIMEDX GROUP, INC. | FTax withholding Common Stock | -61,961 | $5.12 | $317k | 388,662 | Feb 18, 2026 |
| Mar 1, 2024 | MDXG MIMEDX GROUP, INC. | AGrant or award Common Stock | +58,478 | $0.00 | $0 | 459,528 | Mar 5, 2024 |
| Mar 1, 2024 | MDXG MIMEDX GROUP, INC. | AGrant or award Stock Optionsderivative | +70,755 | $0.00 | $0 | 70,755 | Mar 5, 2024 |
| Feb 16, 2024 | MDXG MIMEDX GROUP, INC. | SOpen-market sale Common Stock | -15,493 | $8.07 | $125k | 416,321 | Feb 21, 2024 |
| Feb 20, 2024 | MDXG MIMEDX GROUP, INC. | SOpen-market sale Common Stock | -15,271 | $8.01 | $122k | 401,050 | Feb 21, 2024 |
| Feb 14, 2024 | MDXG MIMEDX GROUP, INC. | SOpen-market sale Common Stock | -15,845 | $8.03 | $127k | 447,012 | Feb 16, 2024 |
| Feb 15, 2024 | MDXG MIMEDX GROUP, INC. | SOpen-market sale Common Stock | -15,198 | $8.06 | $122k | 431,814 | Feb 16, 2024 |
Questions about Ricci S Whitlow
Answered from the filings on this page, as of the latest one.
Is Ricci S Whitlow buying or selling?
Not in the last 12 months. Ricci S Whitlow's latest open-market trade on SEC Form 4 was sold $247k of MDXG on Feb 16, 2024.
How did Ricci S Whitlow's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ricci S Whitlow has 0.
Where does Ricci S Whitlow file Form 4?
Ricci S Whitlow has filed Form 4 at MDXG (MIMEDX GROUP, INC.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.